Phreesia (NYSE:PHR) Given Market Outperform Rating at JMP Securities

Phreesia (NYSE:PHR)‘s stock had its “market outperform” rating reissued by analysts at JMP Securities in a research note issued on Thursday, Benzinga reports. They currently have a $30.00 target price on the stock. JMP Securities’ target price points to a potential upside of 26.10% from the company’s previous close.

PHR has been the subject of several other reports. Royal Bank of Canada restated a “sector perform” rating and issued a $23.00 price objective on shares of Phreesia in a research note on Thursday. Canaccord Genuity Group restated a “buy” rating and set a $34.00 price objective on shares of Phreesia in a research note on Thursday. Truist Financial reiterated a “buy” rating and issued a $29.00 price objective on shares of Phreesia in a research note on Monday, July 1st. Needham & Company LLC restated a “buy” rating and set a $29.00 target price on shares of Phreesia in a research report on Thursday. Finally, KeyCorp lowered their price target on shares of Phreesia from $27.00 to $25.00 and set an “overweight” rating on the stock in a report on Thursday, July 11th. One equities research analyst has rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $30.54.

Phreesia Stock Performance

Shares of PHR traded down $0.38 during trading hours on Thursday, reaching $23.79. 672,269 shares of the company traded hands, compared to its average volume of 465,021. The stock has a market capitalization of $1.37 billion, a P/E ratio of -10.96 and a beta of 0.93. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.03. The business has a fifty day moving average price of $23.24 and a 200-day moving average price of $22.80. Phreesia has a 12-month low of $12.05 and a 12-month high of $30.70.

Insider Transactions at Phreesia

In other Phreesia news, General Counsel Allison C. Hoffman sold 14,110 shares of the stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $26.03, for a total value of $367,283.30. Following the completion of the sale, the general counsel now owns 121,003 shares in the company, valued at approximately $3,149,708.09. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In other news, General Counsel Allison C. Hoffman sold 14,110 shares of Phreesia stock in a transaction on Monday, August 26th. The stock was sold at an average price of $26.03, for a total transaction of $367,283.30. Following the transaction, the general counsel now owns 121,003 shares in the company, valued at approximately $3,149,708.09. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, COO Evan Roberts sold 1,669 shares of the company’s stock in a transaction dated Tuesday, July 16th. The shares were sold at an average price of $23.74, for a total transaction of $39,622.06. Following the completion of the sale, the chief operating officer now directly owns 753,234 shares of the company’s stock, valued at approximately $17,881,775.16. The disclosure for this sale can be found here. Over the last three months, insiders have sold 29,337 shares of company stock valued at $736,750. Corporate insiders own 5.80% of the company’s stock.

Hedge Funds Weigh In On Phreesia

Several large investors have recently modified their holdings of PHR. Vanguard Group Inc. raised its holdings in Phreesia by 4.4% in the 4th quarter. Vanguard Group Inc. now owns 4,628,441 shares of the company’s stock valued at $107,148,000 after buying an additional 194,035 shares during the period. Champlain Investment Partners LLC purchased a new stake in shares of Phreesia in the 1st quarter valued at approximately $29,941,000. Brown Advisory Inc. lifted its holdings in shares of Phreesia by 22.2% in the 4th quarter. Brown Advisory Inc. now owns 3,950,356 shares of the company’s stock worth $91,451,000 after acquiring an additional 716,374 shares during the last quarter. Boston Partners purchased a new position in shares of Phreesia during the 1st quarter worth approximately $669,000. Finally, Blair William & Co. IL increased its holdings in Phreesia by 42.6% in the 1st quarter. Blair William & Co. IL now owns 752,700 shares of the company’s stock valued at $18,012,000 after purchasing an additional 224,950 shares during the last quarter. Institutional investors and hedge funds own 92.10% of the company’s stock.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.